Thus, the optimal treatment protocol (assuming glucose consumption is minimized) is to pick a safe target fasting glucose which avoids the risk of hypoglycemia, and then titrate the insulin dose to achieve this target glucose. The gene discussed is INS; the disease is Hypoglycemia.